Skip to Main Content

Paper Details

Ethical Considerations Related to Return of Results from Genomic Medicine Projects: The eMERGE Network (Phase III) Experience.
J Pers Med
38
2018
109, actionable genes, disease related genes, participant, participants
Author NameAffiliation
David C KochanMayo Clinic
Erin M WinklerCenter for Individualized Medicine and Department of Medical Genomics, Mayo Clinic
Joel E PacynaBiomedical Ethics Research Program, Mayo Clinic
Janet E OlsonBiomedical Ethics Research Program, Mayo Clinic
Stephen N ThibodeauMayo Clinic
John J ConnollyThe Children's Hospital of Philadelphia, Center for Applied Genomics
Margaret HarrThe Children's Hospital of Philadelphia, Center for Applied Genomics
Cynthia A ProwsCincinnati Children's Hospital Medical Center
Beth L CobbCincinnati Children's Hospital Medical Center
Melanie F MyersCincinnati Children's Hospital Medical Center
Bahram NamjouCincinnati Children's Hospital Medical Center
Hila Milo RasoulyColumbia University Medical Center
Julia WynnColumbia University Medical Center
Wendy K ChungColumbia University Medical Center
Wendy K ChungColumbia University Medical Center
Ali G GharaviColumbia University Medical Center
Janet L WilliamsGenomic Medicine Institute
Ingrid A HolmBoston Children's Hospital
Ingrid A HolmBoston Children's Hospital
Sharon AufoxCenter for Genetic Medicine, Northwestern University
Maureen E SmithCenter for Genetic Medicine, Northwestern University
Aaron ScrolKaiser Permanente
Kathleen A LeppigKaiser Permanente
Gail P JarvikUniversity of Washington
Gail P JarvikUniversity of Washington
Georgia L WiesnerVanderbilt University Medical Center
Rongling LiNational Human Genome Research Institute
Rongling LiNational Human Genome Research Institute
Jordan W SmollerCenter for Genomic Medicine, Massachusetts General Hospital
Jordan W SmollerCenter for Genomic Medicine, Massachusetts General Hospital
Richard R SharpBiomedical Ethics Research Program, Mayo Clinic
Iftikhar J KulloMayo Clinic
  • 1 - 32

Datasets